CD14 and COVID-19: applied single-cell RNA sequencing to 284 samples from 196 COVID-19 patients and reported that the percentage of CD14+ monocytes in PBMCs was significantly elevated in COVID-19 patients, especially in COVID-19 hospitalized and critically ill patients [53].